Russell Investments Group’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.9M | Sell |
140,219
-28,943
| -17% | -$3.5M | 0.01% | 858 |
|
|
2026
Q1 | $27.7M | Buy |
169,162
+24,067
| +17% | +$3.7M | 0.03% | 538 |
|
|
2025
Q4 | $25.3M | Sell |
145,095
-21,364
| -13% | -$3.9M | 0.03% | 545 |
|
|
2025
Q3 | $24M | Sell |
166,459
-68,158
| -29% | -$8.35M | 0.03% | 561 |
|
|
2025
Q2 | $23.6M | Sell |
234,617
-68,379
| -23% | -$5.23M | 0.03% | 526 |
|
|
2025
Q1 | $23.1M | Buy |
302,996
+170,842
| +129% | +$13.1M | 0.03% | 528 |
|
|
2024
Q4 | $9.12M | Buy |
132,154
+45,395
| +52% | +$3.27M | 0.01% | 853 |
|
|
2024
Q3 | $6.33M | Buy |
86,759
+31,595
| +57% | +$2.33M | 0.01% | 1061 |
|
|
2024
Q2 | $3.7M | Buy |
55,164
+33,063
| +150% | +$1.28M | 0.01% | 1299 |
|
|
2024
Q1 | $600K | Buy |
22,101
+21,963
| +15,915% | +$615K | ﹤0.01% | 2149 |
|
|
2023
Q4 | $4.28K | Buy |
138
+27
| +24% | +$700 | ﹤0.01% | 2924 |
|
|
2023
Q3 | $2.8K | Sell |
111
-449
| -80% | -$10.3K | ﹤0.01% | 3225 |
|
|
2023
Q2 | $11.8K | Buy |
560
+55
| +11% | +$1.04K | ﹤0.01% | 2932 |
|
|
2023
Q1 | $8.61K | Hold |
505
| – | – | ﹤0.01% | 2905 |
|
|
2022
Q4 | $10.1K | Sell |
505
-105,841
| -100% | -$2.05M | ﹤0.01% | 2845 |
|
|
2022
Q3 | $2.29M | Buy |
106,346
+105,813
| +19,852% | +$2.54M | 0.01% | 1475 |
|
|
2022
Q2 | $10K | Sell |
533
-480
| -47% | -$10.1K | ﹤0.01% | 2845 |
|
|
2022
Q1 | $23K | Sell |
1,013
-39,417
| -97% | -$916K | ﹤0.01% | 2676 |
|
|
2021
Q4 | $1.1M | Sell |
40,430
-3,629
| -8% | -$104K | ﹤0.01% | 2103 |
|
|
2021
Q3 | $1.21M | Sell |
44,059
-6,657
| -13% | -$175K | ﹤0.01% | 2099 |
|
|
2021
Q2 | $1.44M | Sell |
50,716
-10,430
| -17% | -$310K | ﹤0.01% | 2129 |
|
|
2021
Q1 | $2.08M | Sell |
61,146
-57,997
| -49% | -$2.22M | ﹤0.01% | 1852 |
|
|
2020
Q4 | $3.97M | Sell |
119,143
-13,630
| -10% | -$498K | 0.01% | 1372 |
|
|
2020
Q3 | $4.27M | Buy |
132,773
+82,316
| +163% | +$2.37M | 0.01% | 1225 |
|
|
2020
Q2 | $1.39M | Buy |
50,457
+43,165
| +592% | +$1.02M | ﹤0.01% | 1857 |
|
|
2020
Q1 | $116K | Sell |
7,292
-21,759
| -75% | -$516K | ﹤0.01% | 2687 |
|
|
2019
Q4 | $693K | Buy |
+29,051
| New | +$591K | ﹤0.01% | 2284 |
|
|
2019
Q1 | – | Sell |
-6,118
| Closed | -$80K | – | 2954 |
|
|
2018
Q4 | $80K | Hold |
6,118
| – | – | ﹤0.01% | 2751 |
|
|
2018
Q3 | $125K | Sell |
6,118
-20,626
| -77% | -$466K | ﹤0.01% | 2727 |
|
|
2018
Q2 | $633K | Buy |
26,744
+215
| +0.8% | +$5.53K | ﹤0.01% | 2309 |
|
|
2018
Q1 | $598K | Buy |
+26,529
| New | +$698K | ﹤0.01% | 2420 |
|
|
2017
Q2 | – | Sell |
-57,926
| Closed | -$1.01M | – | 2994 |
|
|
2017
Q1 | $1.01M | Buy |
57,926
+39,805
| +220% | +$614K | ﹤0.01% | 2091 |
|
|
2016
Q4 | $242K | Buy |
+18,121
| New | +$247K | ﹤0.01% | 2671 |
|
Other funds holding INSM
BBA
DGM
OAG
Russell Investments Group's INSM Position: Q2 2026 in Review
Russell Investments Group reduced its Insmed (INSM) stake by 17% in Q2 2026, selling an estimated $3.5M and leaving 140,219 shares worth $14.9M. The position accounts for 0.01% of the portfolio, ranked #858.
Russell Investments Group first reported a position in INSM in Q4 2016 and has held it in 33 quarters since. The position peaked at $27.7M in Q1 2026. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Russell Investments Group held 140,219 shares of Insmed worth $14.9M as of Q2 2026.
- Russell Investments Group sold 28,943 Insmed shares in Q2 2026, an estimated $3.5M.
- Insmed made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #858 holding.
- Russell Investments Group first reported a position in Insmed in Q4 2016 and has held it in 33 quarters since.
- Russell Investments Group's Insmed position peaked at $27.7M in Q1 2026.
- 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.